Pharmaceutical news

Collegium Pharmaceutical (NASDAQ:COLL) shareholders are still up 40% over 1 year despite pulling back 6.2% in the past week - Simply Wall St

External page is loading, the page should display in a few seconds..

    Follow @Pharma_NewsUS on Twitter!